PM
MRNA icon

Plustick Management’s Moderna MRNA Stock Holding History

Plustick Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.2M Buy
245,000
+25,000
+11% +$1.29M 6.38% 6
2026
Q1 		$11.2M Buy
220,000
+90,000
+69% +$4.2M 5.4% 5
2025
Q4 		$3.83M Buy
130,000
+70,000
+117% +$1.9M 1.7% 16
2025
Q3 		$1.55M Buy
60,000
+20,000
+50% +$558K 0.65% 18
2025
Q2 		$1.1M Sell
40,000
-30,000
-43% -$790K 0.65% 19
2025
Q1 		$1.98M Buy
+70,000
New +$2.48M 1.45% 17

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Plustick Management's MRNA Position: Q2 2026 in Review

Plustick Management increased its Moderna (MRNA) stake by 11% in Q2 2026, buying an estimated $1.29M and bringing the position to 245,000 shares worth $17.2M. The position accounts for 6.38% of the portfolio, ranked #6.

Plustick Management first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 781 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Plustick Management held 245,000 shares of Moderna worth $17.2M as of Q2 2026.
  • Plustick Management bought 25,000 Moderna shares in Q2 2026, an estimated $1.29M.
  • Moderna made up 6.38% of Plustick Management's portfolio in Q2 2026, its #6 holding.
  • Plustick Management first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 781 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Plustick Management's 13F filing for Q2 2026, filed 14 Aug 2026.